Medicine Man Technologies (Schwazze) Enters Restructuring Deal with Vireo, Plans Major Asset Sale and Liquidation of Remaining Operations
Medicine Man Technologies Inc., operating as Schwazze, has entered into a Restructuring Support Agreement (RSA) with an affiliate of Vireo Growth Inc. and other stakeholders. Under the RSA, the company plans to sell a majority of its assets to a newly formed entity, NewCo, which will be majority-owned by Vireo. Following the asset sale, the remaining operations of the company will be liquidated and wound down. The credit bid for the asset sale will be submitted by the collateral agent for the senior secured notes, and, if successful, NewCo will assume certain liabilities and discharge most of the senior secured notes. NewCo is set to receive up to $62 million in financing to support the transaction, refinance specific debts, and provide working capital. Remaining company assets not included in the sale will be liquidated, with proceeds distributed according to legal priorities.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicine Man Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-099048), on October 14, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。